http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 05 Mar 2026 10:03:57 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+Comments/Jefferies+Reiterates+Buy+Rating+on+Helus+Pharma+%28HELP%29+following+Phase+2+data%3B+%22add%27l+data+is+needed+for+the+Street+to+have+greater+confidence%22/26116640.html <p>Jefferies analyst Andrew Tsai reiterated a Buy rating and $22.00 price target on Helus Pharma (NASDAQ: HELP)</p><p>The analyst commented, "As we await lead drug's HLP003's (oral d-psilocin) first pivotal Phase III readout (APPROACH) in Q4:26 for adjunct MDD (+100-200% stock move), mgmt has shared new Phase II data (N=36) for HLP004 (IM d-DMT) in adjunct GAD generalized anxiety ($1B+ call option) that suggests the shortacting psychedelic has the pot'l to reduce anxiety symptoms rapidly and durably. Ultimately, we think add'l data is needed for the Street to have greater confidence. "</p><p>For an analyst ratings summary and ratings history on Helus http://www.streetinsider.com/Analyst+Comments/Jefferies+Reiterates+Buy+Rating+on+Helus+Pharma+%28HELP%29+following+Phase+2+data%3B+%22add%27l+data+is+needed+for+the+Street+to+have+greater+confidence%22/26116640.html Thu, 05 Mar 2026 10:03:57 -0500 HELP http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Mar+05/26115240.html si-local-file:///var/storage/secattach/20260305/26115240.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Mar+05/26115240.html Thu, 05 Mar 2026 07:54:00 -0500 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Mar+05/26115240.html si-local-file:///var/storage/secattach/20260305/26115240.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Mar+05/26115240.html Thu, 05 Mar 2026 07:54:00 -0500 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Dec+31/26114595.html si-local-file:///var/storage/secattach/20260305/26114595.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Dec+31/26114595.html Thu, 05 Mar 2026 06:04:00 -0500 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Dec+31/26114595.html si-local-file:///var/storage/secattach/20260305/26114595.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Dec+31/26114595.html Thu, 05 Mar 2026 06:04:00 -0500 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Feb+24/26053041.html si-local-file:///var/storage/secattach/20260224/26053041.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Feb+24/26053041.html Tue, 24 Feb 2026 17:17:00 -0500 HELP O.37286706 http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Feb+24/26053041.html si-local-file:///var/storage/secattach/20260224/26053041.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++CYBIN+INC.++++++++++++++++For%3A+Feb+24/26053041.html Tue, 24 Feb 2026 17:17:00 -0500 HELP O.37286706 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Board+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070 http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html <p>Helus Pharma (NASDAQ: HELP) announced the appointment of Dr. Freda Lewis-Hall to its board of directors and as chair of the scientific advisory committee. The clinical-stage pharmaceutical company develops novel serotonergic agonists for mental health conditions.</p> <p>Dr. Lewis-Hall brings more than 40 years of experience in clinical care, research, and biopharmaceutical leadership. She served for over a decade on Pfizer's executive leadership team as executive vice president and chief medical officer, leading a global medical organization in more than 125 countries. She later held the role of chief patient officer at Pfizer.</p> <p>The appointment is subject to approval by Cboe Canada. In http://www.streetinsider.com/Management+Changes/Helus+Pharma+names+former+Pfizer+CMO+to+board+of+directors/26046835.html Tue, 24 Feb 2026 07:45:15 -0500 A.06822034 A.17150087 A.25979495 A.50114125 A.50203840 HELP O.00015895 O.20026344 O.20046146 O.37286706 O.40821812 O.49223070